Safety and Efficacy of Venetoclax (ABT-199/GDC-0199) Monotherapy for Relapsed/Refractory Multiple Myeloma: Phase 1 Preliminary Results
Year: 2015
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Shaji K. Kumar, Ravi Vij, Jonathan L. Kaufman, Joseph R. Mikhael, Thierry Facon, Brigitte Pegourie, Lotfi Benboubker, Philippe Moreau, Martine Amiot, Stefanie Alzate, Lura Morris, Jeremy Ross, Martin Dunbar, Ming Zhu, Paulo Maciag, Suresh Agarwal, Joel Leverson, Sari Heitner Enschede, Rod A. Humerickhouse, Cyrille Touzeau
Institutions: Mayo Clinic, Washington University in St. Louis, Emory University, Winship Cancer Institute, Mayo Clinic in Arizona, Centre Hospitalier Universitaire de Lille, Hôpital Claude Huriez, Centre Hospitalier Universitaire de Grenoble, Hôpital Albert Michallon, Centre Hospitalier Universitaire de Tours, Hôpital Bretonneau, Centre Hospitalier Universitaire de Nantes, AbbVie (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2574117271